Literature DB >> 15885354

Cloning and characterization of hepaCAM, a novel Ig-like cell adhesion molecule suppressed in human hepatocellular carcinoma.

Mei Chung Moh1, Lay Hoon Lee, Shali Shen.   

Abstract

BACKGROUND/AIMS: Previously, we reported on gene HEPN1 that was silenced in hepatocellular carcinoma (HCC) and its capability of arresting cell growth. In this study, we identified another novel gene hepaCAM from the liver, which contains the full-length HEPN1 on its antisense strand in the 3'-noncoding region, and assessed its expression, characteristics and functions in HCC.
METHODS: Full-length hepaCAM cDNA was isolated by rapid amplification of cDNA ends. The gene expression was examined by semi-quantitative RT-PCR in 23 paired HCC liver specimens and 5 HCC cell lines. Transfection studies, coupled with immunocytochemistry, cellular interaction analyses, colony formation and microtetrazolium assay, were employed to elucidate the localization and functions of hepaCAM.
RESULTS: The expression of hepaCAM decreased in 20/23 of HCC samples and was undetectable in 5 HCC cell lines tested. The gene product consisting of 416 amino acids displayed the typical structure of Ig-like cell adhesion molecules. The protein was glycosylated and predominantly localized on the cytoplasmic membrane. When re-expressed in HepG2, hepaCAM accelerated cell spreading (P<0.001), increased cell motility (P=0.0011), reduced colony formation (P=0.0022), and inhibited cell growth (P<0.001).
CONCLUSIONS: Gene hepaCAM, frequently silenced in HCC, encodes an Ig-like transmembrane glycoprotein and is involved in cell adhesion and growth control.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15885354     DOI: 10.1016/j.jhep.2005.01.025

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  24 in total

1.  Identification of novel cell-adhesion molecules in peripheral nerves using a signal-sequence trap.

Authors:  Ivo Spiegel; Konstantin Adamsky; Menahem Eisenbach; Yael Eshed; Adrian Spiegel; Rhona Mirsky; Steven S Scherer; Elior Peles
Journal:  Neuron Glia Biol       Date:  2006-02

2.  Expression and clinical significance of hepaCAM and VEGF in urothelial carcinoma.

Authors:  Shuzhe Yang; Xiaohou Wu; Chunli Luo; Cuicui Pan; Jun Pu
Journal:  World J Urol       Date:  2010-07-01       Impact factor: 4.226

3.  HEPACAM inhibited the growth and migration of cancer cells in the progression of non-small cell lung cancer.

Authors:  Huanzhang Shao; Yinjie Gu; Junli Ding; Peihua Lu; Tingyan Ruan; Wenbin Lu
Journal:  Tumour Biol       Date:  2015-09-22

4.  Miki (Mitotic Kinetics Regulator) Immunoexpression in Normal Liver, Cirrhotic Areas and Hepatocellular Carcinomas: a Preliminary Study with Clinical Relevance.

Authors:  Iván Fernández-Vega; Jorge Santos-Juanes; Emma Camacho-Urkaray; Laura Lorente-Gea; Beatriz García; Francisco Borja Gutiérrez-Corres; Luis M Quirós; Isabel Guerra-Merino; José Javier Aguirre
Journal:  Pathol Oncol Res       Date:  2018-02-12       Impact factor: 3.201

5.  The SMAD2/3 pathway is involved in hepaCAM-induced apoptosis by inhibiting the nuclear translocation of SMAD2/3 in bladder cancer cells.

Authors:  Xiaorong Wang; E Chen; Min Tang; Xue Yang; Yin Wang; Zhan Quan; Xiaohou Wu; Chunli Luo
Journal:  Tumour Biol       Date:  2016-02-12

6.  Frequent alterations of LOH11CR2A, PIG8 and CHEK1 genes at chromosomal 11q24.1-24.2 region in breast carcinoma: clinical and prognostic implications.

Authors:  Satyabrata Sinha; Ratnesh K Singh; Nilanjana Bhattacharya; Nupur Mukherjee; Susmita Ghosh; Neyaz Alam; Anup Roy; Susanta Roychoudhury; Chinmay Kumar Panda
Journal:  Mol Oncol       Date:  2011-07-07       Impact factor: 6.603

7.  Mutant GlialCAM causes megalencephalic leukoencephalopathy with subcortical cysts, benign familial macrocephaly, and macrocephaly with retardation and autism.

Authors:  Tania López-Hernández; Margreet C Ridder; Marisol Montolio; Xavier Capdevila-Nortes; Emiel Polder; Sònia Sirisi; Anna Duarri; Uwe Schulte; Bernd Fakler; Virginia Nunes; Gert C Scheper; Albert Martínez; Raúl Estévez; Marjo S van der Knaap
Journal:  Am J Hum Genet       Date:  2011-03-17       Impact factor: 11.025

8.  Functional significance of the hepaCAM gene in bladder cancer.

Authors:  Yunfeng He; Xiaohou Wu; Chunli Luo; Lie Wang; Jie Lin
Journal:  BMC Cancer       Date:  2010-03-08       Impact factor: 4.430

Review 9.  The roles of cell adhesion molecules in tumor suppression and cell migration: a new paradox.

Authors:  Mei Chung Moh; Shali Shen
Journal:  Cell Adh Migr       Date:  2009-10-12       Impact factor: 3.405

10.  HepaCAM inhibits clear cell renal carcinoma 786-0 cell proliferation via blocking PKCε translocation from cytoplasm to plasma membrane.

Authors:  Bing Tan; Jinxiang Tan; Hongfei Du; Zhen Quan; Xiangdong Xu; Xiaoliang Jiang; Chunli Luo; Xiaohou Wu
Journal:  Mol Cell Biochem       Date:  2014-02-11       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.